Plain-English translation of NCT06514521 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is observing how Pluvicto (a radioactive medication injected to treat advanced prostate cancer) performs and how safe it is in real-world use in South Korea. Researchers are not giving the medication as part of this study—instead, they are tracking men who are already receiving it as part of their regular cancer care. The goal is to understand how well the treatment works and what side effects patients experience in everyday practice.
Even after a medication is approved and patients are using it, doctors need to keep watching how it performs in real life with diverse patients. This study will help ensure the medication is working as expected and that doctors have the best information about how to use it safely.
You likely qualify if…
You likely don't qualify if…
You would continue receiving your treatment exactly as planned—this is not an experimental arm or new treatment protocol. Instead, researchers would collect information from your medical records and follow your progress to see how you respond to the medication and what side effects you experience. This is a passive form of research where you would be monitored as part of regular care rather than completing special study visits or tests.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
South Korea